These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 11904782)
1. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis. Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Jacquy C; Burniat A; Steels E; Vallot F; Sculier JP Support Care Cancer; 2002 Apr; 10(3):181-8. PubMed ID: 11904782 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780 [TBL] [Abstract][Full Text] [Related]
3. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Bohlius J; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474 [TBL] [Abstract][Full Text] [Related]
4. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696 [TBL] [Abstract][Full Text] [Related]
5. Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Mhaskar R; Clark OA; Lyman G; Engel Ayer Botrel T; Morganti Paladini L; Djulbegovic B Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003039. PubMed ID: 25356786 [TBL] [Abstract][Full Text] [Related]
6. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review. Bohlius J; Reiser M; Schwarzer G; Engert A Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668 [TBL] [Abstract][Full Text] [Related]
7. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma. Bohlius J; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2002; (4):CD003189. PubMed ID: 12519588 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Herbst C; Naumann F; Kruse EB; Monsef I; Bohlius J; Schulz H; Engert A Cochrane Database Syst Rev; 2009 Jan; (1):CD007107. PubMed ID: 19160320 [TBL] [Abstract][Full Text] [Related]
9. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Bohlius J; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2004; (1):CD003189. PubMed ID: 14974009 [TBL] [Abstract][Full Text] [Related]
10. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Bohlius J; Herbst C; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003189. PubMed ID: 18843642 [TBL] [Abstract][Full Text] [Related]
11. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Liang DC Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625 [TBL] [Abstract][Full Text] [Related]
12. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia. Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492 [TBL] [Abstract][Full Text] [Related]
13. Colony stimulating factors for chemotherapy induced febrile neutropenia. Clark OA; Lyman G; Castro AA; Clark LG; Djulbegovic B Cochrane Database Syst Rev; 2003; (3):CD003039. PubMed ID: 12917942 [TBL] [Abstract][Full Text] [Related]
14. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF; Chan HO Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic use of colony stimulating factors for established neutropenic fever. Walton SM W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567 [TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. Vellenga E; Uyl-de Groot CA; de Wit R; Keizer HJ; Löwenberg B; ten Haaft MA; de Witte TJ; Verhagen CA; Stoter GJ; Rutten FF; Mulder NH; Smid WM; de Vries EG J Clin Oncol; 1996 Feb; 14(2):619-27. PubMed ID: 8636779 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Bo L; Wang F; Zhu J; Li J; Deng X Crit Care; 2011; 15(1):R58. PubMed ID: 21310070 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus. Ambati BK; Perlman DC; Salomon N Int J Infect Dis; 1998-1999 Winter; 3(2):70-5. PubMed ID: 10225983 [TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of febrile neutropenia]. Montemurro F; Gallicchio M; Aglietta M Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724 [TBL] [Abstract][Full Text] [Related]
20. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]